⏳ Final hours! Save up to 60% OFF InvestingProCLAIM SALE

Israel stocks lower at close of trade; TA 35 down 0.96%

Published 03/19/2018, 12:00 PM
Updated 03/19/2018, 12:05 PM
© Reuters.  Israel stocks lower at close of trade; TA 35 down 0.96%
TA35
-
CEL
-
MLSR
-
NICE
-
PTNR
-
TEVA
-
TELBANK5
-
TACOMMIT
-
BIOMED
-
ORA
-

Investing.com – Israel stocks were lower after the close on Monday, as losses in the Biomed, Communication and Banking sectors led shares lower.

At the close in Tel Aviv, the TA 35 lost 0.96%.

The best performers of the session on the TA 35 were Ormat Technologies (TA:ORA), which rose 1.55% or 290 points to trade at 19060 at the close. Meanwhile, Nice Ltd (TA:NICE) added 1.50% or 500 points to end at 33780 and Melisron (TA:MLSR) was up 1.11% or 160 points to 14550 in late trade.

The worst performers of the session were Partner (TA:PTNR), which fell 3.42% or 61 points to trade at 1721 at the close. Cellcom Israel Ltd (TA:CEL) declined 2.47% or 66 points to end at 2601 and Teva Pharmaceutical Industries Ltd (TA:TEVA) was down 2.28% or 146 points to 6244.

Falling stocks outnumbered advancing ones on the Tel Aviv Stock Exchange by 295 to 98 and 17 ended unchanged.

Crude oil for May delivery was down 0.56% or 0.35 to $62.06 a barrel. Elsewhere in commodities trading, Brent oil for delivery in May fell 0.29% or 0.19 to hit $66.02 a barrel, while the April Gold Futures contract rose 0.53% or 7.00 to trade at $1319.30 a troy ounce.

USD/ILS was up 0.36% to 3.4701, while EUR/ILS rose 0.71% to 4.2796.

The US Dollar Index Futures was down 0.39% at 89.45.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.